首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Trauma patients' elevated tumor necrosis related apoptosis inducing ligand (TRAIL) contributes to increased T cell apoptosis
【24h】

Trauma patients' elevated tumor necrosis related apoptosis inducing ligand (TRAIL) contributes to increased T cell apoptosis

机译:创伤患者的肿瘤坏死相关凋亡诱导配体(TRAIL)升高导致T细胞凋亡增加

获取原文
获取原文并翻译 | 示例
           

摘要

Immunosuppression resulting from excessive post-trauma apoptosis of hyperactivated T cells is controversial. TRAIL mediated T cell apoptosis decreases highly activated T cells' responses. Caspase-10, a particular TRAIL target, was increased in trauma patients' T cells with concomitantly elevated plasma TRAIL levels. These patients' T cells developed anergy, implicating increased TRAIL-mediated T cell apoptosis in post-trauma T cell anergy. Control T cells cultured with patients' sera containing high TRAIL levels increased their caspase-10 activity and apoptosis. Stimulated primary T cells are TRAIL apoptosis resistant. Increased plasma thrombospondin-1 and T cell expression of CD47, a thrombospondin-1 receptor, preceded patients' T cell anergy. CD47 triggering of T cells increased their sensitivity to TRAIL-induced apoptosis. Augmentation of T cell TRAIL-induced apoptosis was secondary to CD47 triggered activation of the Src homology-containing phosphatase-1 (SHP-1) and was partially blocked by a SHP-1 inhibitor. We suggest that combined post-trauma CD47 triggering, SHP-1 mediated NFκB suppression, and elevated TRAIL levels increase patients' CD47 expressing T cell apoptosis, thus contributing to subsequent T cell anergy.
机译:创伤后过度活化的T细胞凋亡过多导致的免疫抑制作用存在争议。 TRAIL介导的T细胞凋亡降低了高度活化的T细胞的反应。 Caspase-10(一种特殊的TRAIL靶标)在创伤患者的T细胞中升高,同时血浆TRAIL水平升高。这些患者的T细胞无反应,提示创伤后T细胞无反应时TRAIL介导的T细胞凋亡增加。用含有高TRAIL水平的患者血清培养的对照T细胞可增加其caspase-10活性和细胞凋亡。刺激的原代T细胞对TRAIL凋亡具有抗性。血浆血小板反应蛋白-1和血小板反应蛋白-1受体CD47的T细胞表达增加,先于患者T细胞无反应。 CD47触发T细胞增加了它们对TRAIL诱导的细胞凋亡的敏感性。 T细胞TRAIL诱导的细胞凋亡增强是CD47继发的激活含Src同源性的磷酸酶1(SHP-1)的激活,并被SHP-1抑制剂部分阻断。我们建议,创伤后CD47触发,SHP-1介导的NFκB抑制和TRAIL水平升高相结合,会增加患者CD47表达的T细胞凋亡,从而促进随后的T细胞无反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号